Table 1. Demographic data of the study subjects.
Number of samples from different patients and controls, and site of collection.
| Subjects | Sex | Age (yr) | |||
|---|---|---|---|---|---|
| M | F | Median | Min-max | Kruskal-Wallis (p) | |
| Visceral Leishmaniasis (n = 128) | 86 | 39 | 25.5 | 1–90 | <0.001 |
| Campo Grande (n = 27) | 19 | 8 | 43 a | 1–90 | |
| Bauru (n = 16) | 9 | 7 | 16.5 | 1–59 | |
| Aracaju (n = 55) | 35 | 20 | 9.5 | 1–68 | |
| Natal (n = 30) | 23 | 4 | 33 | 15–56 | |
| Asymptomatic control (n = 85) | 46 | 39 | 30 | 2–67 | <0.001 |
| Campo Grande (n = 31) | 20 | 11 | 34 | 4–67 | |
| Bauru (n = 7) | 0 | 7 | 32 | 29–35 | |
| Aracaju (n = 14) | 6 | 8 | 9.5 b | 2–33 | |
| Natal (n = 33) | 20 | 13 | 29 | 16–60 | |
| Potentially cross-reactive control (n = 22) | - | - | - | - | |
| Campo Grande (n = 7) | 4 | 3 | 43 | 25–74 | |
| Sao Paulo (n = 15) | - | - | - | - | |
| Visceral Leishmaniasis/aids (n = 20) | 12 | 8 | 36 | 20–53 | 0.667 |
| Campo Grande (n = 11) | 8 | 3 | 37 | 20–53 | |
| Bauru (n = 5) | 3 | 2 | 43 | 23–53 | |
| Natal (n = 4) | 1 | 3 | 31 | 21–46 | |
n–Number of samples.
M–Male. F–Female.
Min-max–minimum-maximum.
a–p<0.001 (Kruskal-Wallis) in relation to Bauru and Aracaju.
b–p<0.001 in relation to Bauru, Campo Grande, and Natal.